2005
DOI: 10.1016/j.clinthera.2005.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: A randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
36
1
1

Year Published

2009
2009
2017
2017

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 70 publications
(41 citation statements)
references
References 20 publications
3
36
1
1
Order By: Relevance
“…Similarly, a study of dental pain following extraction of impacted third molars that compared the oxycodone/acetaminophen (5 mg/325 mg) and hydrocodone/acetaminophen (7.5 mg/500 mg) did not find sizeable or statistically significant differences in pain intensity or pain relief summed over a 6-hour period following a single dose of each combination analgesic. 6 In our study, nausea was significantly more common in patients treated with oxycodone/acetaminophen than those treated with hydrocodone/acetaminophen (17.1% vs. 7.1%, respectively; Table 3). The magnitude and direction of the findings are somewhat similar to those of the postoperative dental study (23% vs. 16%, respectively), although that difference was not statistically significant.…”
Section: Discussionmentioning
confidence: 78%
See 2 more Smart Citations
“…Similarly, a study of dental pain following extraction of impacted third molars that compared the oxycodone/acetaminophen (5 mg/325 mg) and hydrocodone/acetaminophen (7.5 mg/500 mg) did not find sizeable or statistically significant differences in pain intensity or pain relief summed over a 6-hour period following a single dose of each combination analgesic. 6 In our study, nausea was significantly more common in patients treated with oxycodone/acetaminophen than those treated with hydrocodone/acetaminophen (17.1% vs. 7.1%, respectively; Table 3). The magnitude and direction of the findings are somewhat similar to those of the postoperative dental study (23% vs. 16%, respectively), although that difference was not statistically significant.…”
Section: Discussionmentioning
confidence: 78%
“…7 In our study, dizziness was also significantly more frequent in patients who received oxycodone/acetaminophen (5 mg/325 mg) than in those who received hydrocodone/acetaminophen (5 mg/325 mg; 17.0% vs. 7.2%; Table 3). Litkowski et al 6 detected no difference in the incidences of dizziness between oxycodone/acetaminophen (5 mg/325 mg) and hydrocodone/acetaminophen (5 mg/325 mg), which they found to be 5% versus 2%, respectively. The incidences of dizziness in two other studies were 10% for oxycodone/acetaminophen (5 mg/325 mg) 8 and 14% for hydrocodone/acetaminophen (5 mg/325 mg).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…2 The popularity of hydrocodone/acetaminophen postdischarge is supported by two small clinical trials, 3,4 and several other studies that compare the efficacy of commonly prescribed oral opioids in different settings. [5][6][7][8][9] There has been increasing concern about the abuse of oral opioids in patients discharged from the ED. 10,11 The efficacy of hydrocodone versus codeine has not been adequately studied among discharged adult ED patients with acute pain.…”
mentioning
confidence: 99%
“…Th e same reviewer assessed the full text articles and determined that 14 of the 26 off ered quantitative results that could be analyzed using the GRADE-pro software [28][29][30][31][32][33][34][35][36][37][38][39][40][41]. Th e remaining 12 articles were excluded because they did not compare both drugs assessed in a PICO question [42][43][44][45][46][47], compared analgesics not addressed in the seven P ICO qu estions (such as acetaminophen alone) [48,49], used unconventional medication dosing [50,51], used non-validated pain me asurement scales [52,53], and/or unusual study designs [50].…”
Section: Resultsmentioning
confidence: 99%